Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials David M. WilliamsAsif NawazMarc Evans Review Open access 20 December 2019 Pages: 369 - 386
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review Andrej JanežCristian GujaLea Smircic-Duvnjak Review Open access 04 January 2020 Pages: 387 - 409
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel Sanjay KalraA. K. DasKhalid Shaikh Review Open access 08 January 2020 Pages: 411 - 422
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe Gian Paolo FadiniNikolaos TentolourisCristóbal Morales Portillo Original Research Open access 20 December 2019 Pages: 423 - 436
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study Irene RomeraSilvia DíazJesús Reviriego Original Research Open access 28 December 2019 Pages: 437 - 451
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study Tsvetalina TankovaAtanaska ElenkovaReneta Petkova Original Research Open access 02 January 2020 Pages: 453 - 465
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice Tibor HidvégiZoltán BaloghPéter Stella Original Research Open access 03 January 2020 Pages: 467 - 478
Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes Alireza MirahmadizadehHaniyeh KhorshidsavarMohammad Hossein Sharifi Original Research Open access 08 January 2020 Pages: 479 - 494
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study Chantal MathieuS. John WeisnagelKathy Alexandre Original Research Open access 10 January 2020 Pages: 495 - 507
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain Josep VidalSamuel J. P. MalkinFrancisco Javier Ortega Original Research Open access 10 January 2020 Pages: 509 - 521
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study Fumiko YamamotoRie IkedaTomoo Okamura Original Research Open access 13 January 2020 Pages: 523 - 533
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database Corinne EmeryElodie TorretonBruno Detournay Original Research Open access 17 January 2020 Pages: 535 - 548
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Yumie TakeshitaTakehiro KanamoriToshinari Takamura Study Protocol Open access 20 January 2020 Pages: 549 - 560
Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019 Thomas R. PieberLars BardtrumRimei Nishimura Commentary Open access 10 January 2020 Pages: 561 - 567
Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance Yu-peng LiZhong-qing YanYun Xie Correction Open access 21 December 2019 Pages: 569 - 570
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes Marc EvansDebbie HicksUmesh Dashora Correction Open access 31 December 2019 Pages: 571 - 571